Languages

info@iozk.de

Deutsch German de
English English en
Español Spanish es
Русский Russian ru
polski Polish pl

Home
The IOZK
The IOZK Immunotherapy
Expert Knowledge
News
Contact
Menu Menu

Nothing Found

Sorry, no posts matched your criteria

New Posts

IOZK Webinar at the World Cancer Series2024-11-18 - 10:13
New IOZK publication on liquid biopsy2023-11-07 - 17:35
Stefaan van Gool appointed as editor of a special issue by the Journal of Molecular Sciences2023-01-23 - 16:16

SPECIALISTS IN IMMUNO-ONCOLOGY

Interesting Facts

Evidence Based Medicine2023-02-01 - 10:15
IOZK Laboratories2020-04-29 - 09:03
Patient information – IOZK Foundation2020-04-29 - 09:03
Warmth against Cancer: Therapeutic Hyperthermia2019-06-24 - 14:20
What is Immunotherapy?2019-06-24 - 14:18
Personalized Medicine in Oncology2019-06-24 - 14:17
Viruses Against Cancer: Oncolytic Virotherapy2019-06-24 - 13:53
Dendritic Cells Inform the Immune System2019-06-19 - 12:56
The Development of Cancer2019-06-19 - 12:52
Nobel Prizes for Immunotherapy2019-06-19 - 09:25

Tags

IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Cologne | Germany

T: +49 (0)221 – 420 399 25
F: +49(0)221 - 420 399 26
E-Mail: info@iozk.de

The IOZK

Philosophy
Team
Treatment Center
Laboratories
Directions and Accommodation

The IOZK Immunotherapy

IOZK Immunotherapy
The Vaccine IO-VAC®
The Treatment
IOZK Immunotherapy for Different Types of Cancer
Therapy Costs
FAQ

News

IOZK Webinar at the World Cancer Series
New IOZK publication on liquid biopsy
Stefaan van Gool appointed as editor of a special issue by the Journal of Molecular Sciences

Privacy Statement
Cookie Settings

Scroll to top